Page last updated: 2024-10-30

meprobamate and Fatty Liver

meprobamate has been researched along with Fatty Liver in 1 studies

Meprobamate: A carbamate with hypnotic, sedative, and some muscle relaxant properties, although in therapeutic doses reduction of anxiety rather than a direct effect may be responsible for muscle relaxation. Meprobamate has been reported to have anticonvulsant actions against petit mal seizures, but not against grand mal seizures (which may be exacerbated). It is used in the treatment of ANXIETY DISORDERS, and also for the short-term management of INSOMNIA but has largely been superseded by the BENZODIAZEPINES. (From Martindale, The Extra Pharmacopoeia, 30th ed, p603)

Fatty Liver: Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Held, H1
von Oldershausen, HF1

Other Studies

1 other study available for meprobamate and Fatty Liver

ArticleYear
[Pharmacokinetics of meprobamate in chronic liver diseases and drug addiction].
    Klinische Wochenschrift, 1969, Jan-15, Volume: 47, Issue:2

    Topics: Adult; Aged; Fatty Liver; Female; Hepatitis; Humans; Kinetics; Liver Cirrhosis; Male; Meprobamate; M

1969